Literature DB >> 17439174

The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.

Josephine A Czechowicz1, April K Wilhelm, Maroya D Spalding, Anna M Larson, Linnea K Engel, David G Alberg.   

Abstract

Trypanothione reductase (TR) catalyzes the NADPH-dependent reduction of trypanothione disulfide (1). TR plays a central role in the trypanosomatid parasite's defense against oxidative stress and has emerged as a promising target for antitrypanosomal drugs. We describe the synthesis and activity of dethiotrypanothione and analogues (2-4) as inhibitors of Trypanosoma cruzi TR. The syntheses of these macrocycles feature ring-closing olefin metathesis (RCM) reactions catalyzed by ruthenium catalyst 17. Derivative 4 is our most potent inhibitor with a Ki=16 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439174      PMCID: PMC2528058          DOI: 10.1021/jo062597s

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  23 in total

1.  Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress.

Authors:  S Krieger; W Schwarz; M R Ariyanayagam; A H Fairlamb; R L Krauth-Siegel; C Clayton
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

2.  Inhibition of trypanothione reductase by substrate analogues.

Authors:  E A Garrard; E C Borman; B N Cook; E J Pike; D G Alberg
Journal:  Org Lett       Date:  2000-11-16       Impact factor: 6.005

Review 3.  Parasite-specific trypanothione reductase as a drug target molecule.

Authors:  R Luise Krauth-Siegel; Oliver Inhoff
Journal:  Parasitol Res       Date:  2003-04-23       Impact factor: 2.289

Review 4.  The application of olefin metathesis to the synthesis of biologically active macrocyclic agents.

Authors:  Pierre Van de Weghe; Jacques Eustache
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

5.  3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT): a new coupling reagent with remarkable resistance to racemization.

Authors:  H Li; X Jiang; Y H Ye; C Fan; T Romoff; M Goodman
Journal:  Org Lett       Date:  1999-07-15       Impact factor: 6.005

6.  Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands.

Authors:  M Scholl; S Ding; C W Lee; R H Grubbs
Journal:  Org Lett       Date:  1999-09-23       Impact factor: 6.005

7.  Recent methods for the synthesis of (E)-alkene units in macrocyclic natural products.

Authors:  Joëlle Prunet
Journal:  Angew Chem Int Ed Engl       Date:  2003-06-30       Impact factor: 15.336

8.  Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.

Authors:  Ahilan Saravanamuthu; Tim J Vickers; Charles S Bond; Mark R Peterson; William N Hunter; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

9.  Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases.

Authors:  S L Shames; A H Fairlamb; A Cerami; C T Walsh
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

10.  Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids.

Authors:  A H Fairlamb; P Blackburn; P Ulrich; B T Chait; A Cerami
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

View more
  1 in total

1.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.